Mostrar el registro sencillo del ítem

dc.contributor.authorMaria Torrens, Juana
dc.contributor.authorOrellana-Gavalda, Josep M
dc.contributor.authorPalou, Mariona
dc.contributor.authorSanchez, Juana
dc.contributor.authorHerrero, Laura
dc.contributor.authorPicó, Catalina
dc.contributor.authorSerra, Dolors
dc.contributor.authorPalou, Andreu
dc.date.accessioned2024-07-03T11:01:18Z
dc.date.available2024-07-03T11:01:18Z
dc.date.issued2014
dc.identifier.citationMaria Torrens J, Orellana-Gavalda JM, Palou March M, Sánchez J, Herrero L, Pico C, et al. Enhancing Hepatic Fatty Acid Oxidation as a Strategy for Reversing Metabolic Disorders Programmed by Maternal Undernutrition During Gestation. Cell Physiol Biochem. 2014;33(5):1498-515. Epub 2014 May 14.en
dc.identifier.issn1015-8987
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/11863
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19959
dc.description.abstractBackground/Aims: Moderate maternal calorie-restriction during gestation programmes offspring for a major propensity to develop metabolic alterations in adulthood. We aimed to assess whether increased hepatic fatty-acid oxidation (FAO), at early ages, by gene transfer of Cpt1am (active mutant of carnitine palmitoyltransferase-1a), may be a strategy for reversing metabolic disturbances associated to maternal calorie-restriction during gestation in rats. Methods: AAV-Gfp (control) and AAV-Cpt1am vectors were administered by tail vein injection in 18-day-old control-pups and the offspring of 20% calorie-restricted rats during gestation (CR). After weaning, animals were fed with normal-fat diet. At the age of 4 months, they were moved to HF-diet and sacrificed at the age of 6 months to collect tissues. Locomotive activity, energy expenditure and blood pressure were measured. Results: Under HF-diet, CR-animals showed higher HOMA-IR, adipocyte diameter and hepatic triglyceride accumulation than controls; these alterations were reverted in Cpt1am-injected animals. In liver, this treatment ameliorated inflammatory state, decreased expression of lipogenesis-related genes and partially restored the decreased expression of leptin-receptor occurring in CR-animals. Treatment also reverted the decreased energy expenditure and the increased blood pressure of CR-animals. Conclusion: Increasing hepatic FAO through AAV-Cpt1am injection at juvenile ages prevents some metabolic disorders associated to gestational maternal calorie-restriction.en
dc.description.sponsorshipWe thank Enzo Ceresi for his help in morphological techniques. We gratefully acknowledge the Spanish Government (grant AGL2012-33692 to A. P., grant SAF2010-20039 to L. H. and grant SAF2011-30520-C02-01 to D. S.), the European Union (BIOCLAIMS FP7-244995 to A. P.), the Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), EFSD/Lilly and EFSD/Janssen (research fellowships to LH) and by L'Oreal-UNESCO (research fellowship to LH). The Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics) is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, EU Contract: no FP6-506360).es_ES
dc.language.isoengen
dc.publisherKarger Publishers en
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/*
dc.subjectCpt1a
dc.subjectCalorie restriction
dc.subjectGestation
dc.subjectGene transference
dc.subjectLiver
dc.subject.meshMalnutrition *
dc.subject.meshPregnancy, Animal *
dc.subject.meshHumans *
dc.subject.meshMetabolic Diseases *
dc.subject.meshCarnitine O-Palmitoyltransferase *
dc.subject.meshFatty Acids *
dc.subject.meshFatty Liver *
dc.subject.meshPregnancy *
dc.subject.meshMale *
dc.subject.meshGenetic Therapy *
dc.subject.meshPregnancy Complications *
dc.subject.meshRats, Wistar *
dc.subject.meshFemale *
dc.subject.meshRats *
dc.subject.meshAnimals *
dc.subject.meshOxidation-Reduction *
dc.subject.meshPrenatal Exposure Delayed Effects *
dc.titleEnhancing Hepatic Fatty Acid Oxidation as a Strategy for Reversing Metabolic Disorders Programmed by Maternal Undernutrition During Gestationen
dc.typeresearch articleen
dc.rights.licenseAttribution-NonCommercial 3.0 Unported*
dc.identifier.pubmedID24854839es_ES
dc.format.volume33es_ES
dc.format.number5es_ES
dc.format.page1498-1515es_ES
dc.identifier.doi10.1159/000358714
dc.identifier.e-issn1421-9778es_ES
dc.relation.publisherversionhttps://dx.doi.org/10.1159/000358714en
dc.identifier.journalCellular Physiology and Biochemistryes_ES
dc.rights.accessRightsopen accessen
dc.subject.decsPreñez*
dc.subject.decsAnimales*
dc.subject.decsRatas Wistar*
dc.subject.decsTerapia Genética*
dc.subject.decsFemenino*
dc.subject.decsMasculino*
dc.subject.decsDesnutrición*
dc.subject.decsEnfermedades Metabólicas*
dc.subject.decsHígado Graso*
dc.subject.decsCarnitina O-Palmitoiltransferasa*
dc.subject.decsRatas*
dc.subject.decsHumanos*
dc.subject.decsÁcidos Grasos*
dc.subject.decsComplicaciones del Embarazo*
dc.subject.decsEmbarazo*
dc.subject.decsEfectos Tardíos de la Exposición Prenatal*
dc.subject.decsOxidación-Reducción*
dc.identifier.scopus2-s2.0-84901334432
dc.identifier.wos336493300022
dc.identifier.puiL373159366


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial 3.0 Unported
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial 3.0 Unported